Covid-19 roundup: Study shows J&J's shot is much less effective against Delta variant; Novartis open to manufacturing other coronavirus vaccines — report

Nicole DeFeudis

Editor

As the Delta variant rapidly spreads across the US — accounting for 83% of the country’s cases, CDC director Rochelle Walensky said yesterday — a new …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Study shows J&J's shot is much less effective against Delta variant; Novartis open to manufacturing other coronavirus vaccines — report

Nicole DeFeudis

Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA approves first drug to treat ultra-rare lipid storage disease

FDA says Ozempic, Wegovy shortage is over

How AI can address ongoing challenges in the life sciences industry

Covid-19 roundup: Study shows J&J's shot is much less ef­fec­tive against Delta vari­ant; No­var­tis open to man­u­fac­tur­ing oth­er coro­n­avirus vac­cines — re­port

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Covid-19 roundup: Study shows J&J's shot is much less effective against Delta variant; Novartis open to manufacturing other coronavirus vaccines — report